STERIS plc (FRA:2TG)

Market Cap	20.87B -0.3%
Revenue (ttm)	4.96B +8.0%
Net Income	602.78M +51.3%
EPS	6.10 +51.8%
Shares Out	n/a
PE Ratio	34.62
Forward PE	23.11
Dividend	2.27 (1.08%)
Ex-Dividend Date	Feb 17, 2026

Volume	n/a
Average Volume	5
Open	210.00
Previous Close	212.00
Day's Range	210.00 - 210.00
52-Week Range	198.00 - 232.00
Beta	n/a
RSI	45.81
Earnings Date	Feb 4, 2026

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1985
• Employees: 17,787
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2TG

Financial Performance

In fiscal year 2025, STERIS's revenue was $5.46 billion, an increase of 6.24% compared to the previous year's $5.14 billion. Earnings were $614.64 million, an increase of 62.50%.

Financial numbers in USD